OTLK Outlook Therapeutics Inc.

1.1
0  0%
Previous Close 1.1
Open 1.1
Price To Book -3.67
Market Cap 93600168
Shares 85,091,062
Volume 132,417
Short Ratio
Av. Daily Volume 303,499

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 trial 75% enrolled as of February 14, 2019.
ONS-5010
Wet age-related macular degeneration (wet AMD)